Gold soars to record high over $3,900/oz amid yen slump, US rate cut bets
Mario Schlosser, President of Technology & CTO at Oscar Health, Inc. (NASDAQ:OSCR), sold 395,000 shares of Class A Common Stock on September 22, 2025. The shares were sold at a price of $18.43, for a total value of $7,279,850. The prices for the sale ranged from $18.25 to $18.78. On the same day, Schlosser also acquired 395,000 shares of Class A Common Stock.
In other recent news, Oscar Health reported second-quarter earnings that did not meet analyst expectations. The company posted an earnings per share (EPS) of -$0.89, falling short of the forecasted -$0.84, and revenue was reported at $2.86 billion, below the anticipated $2.92 billion. Additionally, Oscar Health announced the issuance of $410 million in convertible senior subordinated notes due in 2030, with net proceeds of approximately $395.8 million after expenses. The company intends to use the remaining funds for general corporate purposes after allocating $34.4 million for capped call transactions.
In a related development, Oscar Health initially planned to offer $350 million in convertible notes, with an option for purchasers to buy an additional $52.5 million. The proceeds from this offering are intended to support general corporate purposes, including expansion opportunities in artificial intelligence and enhancing member experiences. Piper Sandler has adjusted its price target for Oscar Health to $13 from $14, maintaining a Neutral rating due to mixed second-quarter results. These updates reflect the company’s ongoing financial and strategic activities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.